News
1hon MSN
Not just a messenger: Developing nano-sized delivery agents that also provide therapeutic treatment
A group of University of Ottawa researchers have already shown how scientists can harness gene therapies to deliver ...
Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of ...
A University of Florida study shows an mRNA vaccine combined with immunotherapy drugs significantly boosts the immune systems ...
A group of scientists from the Angiogenesis Unit of the Biomedical Research Centre of La Rioja (CIBIR) has succeeded in creating a vaccine, based on messenger RNA technology, that ...
Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business ...
An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse model study, bringing researchers ...
4d
News-Medical.Net on MSNNew mRNA vaccine strategy awakens immune system to fight cancer
An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers ...
StockStory.org on MSN6d
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results